LEAC-102 for Advanced Colorectal Cancer

NCT02826837 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Colorectal Cancer

Interventions

DRUG: LEAC-102 500mg capsule and FOLFOX + Bevacizumab/Cetuximab

Sponsor

Taiwan Leader Biotech Corp.